Anti-IFNA1/ IFNA13 functional antibody

Anti-IFNA1/ IFNA13 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IFNA13/IFNA13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0977-Ab-1/ GM-Tg-hg-SE0977-Ab-2Anti-Human IFNA13 monoclonal antibodyHuman
GM-Tg-rg-SE0977-Ab-1/ GM-Tg-rg-SE0977-Ab-2Anti-Rat IFNA13 monoclonal antibodyRat
GM-Tg-mg-SE0977-Ab-1/ GM-Tg-mg-SE0977-Ab-2Anti-Mouse IFNA13 monoclonal antibodyMouse
GM-Tg-cynog-SE0977-Ab-1/ GM-Tg-cynog-SE0977-Ab-2Anti-Cynomolgus/ Rhesus macaque IFNA13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0977-Ab-1/ GM-Tg-felg-SE0977-Ab-2Anti-Feline IFNA13 monoclonal antibodyFeline
GM-Tg-cang-SE0977-Ab-1/ GM-Tg-cang-SE0977-Ab-2Anti-Canine IFNA13 monoclonal antibodyCanine
GM-Tg-bovg-SE0977-Ab-1/ GM-Tg-bovg-SE0977-Ab-2Anti-Bovine IFNA13 monoclonal antibodyBovine
GM-Tg-equg-SE0977-Ab-1/ GM-Tg-equg-SE0977-Ab-2Anti-Equine IFNA13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0977-Ab-1/ GM-Tg-hg-SE0977-Ab-2; GM-Tg-rg-SE0977-Ab-1/ GM-Tg-rg-SE0977-Ab-2;
GM-Tg-mg-SE0977-Ab-1/ GM-Tg-mg-SE0977-Ab-2; GM-Tg-cynog-SE0977-Ab-1/ GM-Tg-cynog-SE0977-Ab-2;
GM-Tg-felg-SE0977-Ab-1/ GM-Tg-felg-SE0977-Ab-2; GM-Tg-cang-SE0977-Ab-1/ GM-Tg-cang-SE0977-Ab-2;
GM-Tg-bovg-SE0977-Ab-1/ GM-Tg-bovg-SE0977-Ab-2; GM-Tg-equg-SE0977-Ab-1/ GM-Tg-equg-SE0977-Ab-2
Products NameAnti-IFNA13 monoclonal antibody
Formatmab
Target NameIFNA13
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFNA13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0977-Ag-1Recombinant multi-species IFNA1/ IFNA13 protein
    CytokineGM-Tg-g-SE0977-Ag-1interferon, alpha 13 (IFNA13) protein
    ORF Viral VectorvGMLP000155human IFNA13 Lentivirus particle
    ORF Viral VectorpGMLP000155human IFNA13 Lentivirus plasmid


    Target information

    Target IDGM-SE0977
    Target NameIFNA13
    Gene ID3447
    Gene Symbol and SynonymsIFNA13
    Uniprot AccessionP01562
    Uniprot Entry NameIFNA1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000233816
    Target ClassificationN/A

    The target: IFNA13, gene name: IFNA13, also named as . Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to be located in extracellular region. Predicted to be active in extracellular space..



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.